Urinary metabolites and antioxidant products of exogenous melatonin in the mouse
- 21 April 2006
- journal article
- Published by Wiley in Journal of Pineal Research
- Vol. 40 (4), 343-349
- https://doi.org/10.1111/j.1600-079x.2006.00321.x
Abstract
Exogenous melatonin is widely used for sleep disorders and has potential value in neuroprotection, cardioprotection and as an antioxidant. Here, a novel method is described for the determination of melatonin and six metabolites in mouse urine by use of LC‐MS/MS and GC‐MS. LC‐MS/MS is used for the measurement of melatonin, N1‐acetyl‐5‐methoxykynuramine (AMK), N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine (AFMK) and 6‐hydroxymelatonin (6‐HMEL), while GC/MS is used for the determination of N‐[2‐(5‐methoxy‐2‐oxo‐2,3‐dihydro‐1H‐indol‐3‐yl)‐ethyl]‐acetamide (2‐OMEL) and cyclic 3‐hydroxymelatonin (3‐HMEL) with detection limits on column of 0.02–0.5 pmol, depending on the metabolite. Following oral administration of melatonin to mice, a 0–24 hr urine collection revealed the presence of melatonin (0.2% dose), 6‐HMEL (37.1%) and NAS (3.1%) comprising >90% of the total metabolites; AMK and AFMK were also detected at 0.01% each; 2‐OMEL was found at 2.2% of the dose, which is >100 times more than the AMK/AFMK pathway, and comprises >5% of the melatonin‐related material detected in mouse urine. 3‐HMEL was largely found as a sulfate conjugate. These studies establish sensitive assays for determination of six melatonin metabolites in mouse urine and confirm the potential for antioxidant activity of melatonin through the identification in vivo of AMK and AFMK, ring‐opened metabolites with a high capacity for scavenging reactive oxygen species.Keywords
This publication has 36 references indexed in Scilit:
- Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophagesJournal of Neuroimmunology, 2005
- METABOLISM OF MELATONIN BY HUMAN CYTOCHROMES P450Drug Metabolism and Disposition, 2004
- Oxidation of melatonin and its catabolites, N1‐acetyl‐N 2‐formyl‐5‐methoxykynuramine and N1‐acetyl‐5‐methoxykynuramine, by activated leukocytesJournal of Pineal Research, 2004
- Amelioration of methotrexate‐induced enteritis by melatonin in ratsCell Biochemistry and Function, 2004
- Melatonin protects against oxidative stress caused by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in the mouse nigrostriatumJournal of Pineal Research, 2003
- Prevention of apoptotic and necrotic cell death, caspase‐3 activation, and renal dysfunction by melatonin after ischemia/reperfusionThe FASEB Journal, 2003
- Actions of melatonin in the reduction of oxidative stressJournal of Biomedical Science, 2000
- A Novel Melatonin Metabolite, Cyclic 3-Hydroxymelatonin: A Biomarker ofin VivoHydroxyl Radical GenerationBiochemical and Biophysical Research Communications, 1998
- Oral administration and distribution of melatonin in human serum, saliva and urineLife Sciences, 1985
- Melatonin administration to dogsJournal of Neural Transmission, 1980